Patents by Inventor Seán KINSELLA

Seán KINSELLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076599
    Abstract: An electroporation apparatus has an electroporation probe terminals for linking with electrodes. A foam is injected at the treatment site to displace blood rather than mixing with it, increasing the contact time of a higher concentration of active agent with the tissue and thus resulting in greater efficacy. With foam solutions, a lower concentration of agent can be used to obtain the same therapeutic effect as in their liquid counterpart, reducing the prevalence of side effects associated with higher concentrations. A foam solution compared to an equivalent liquid solution enables more efficient cell electroporation particularly where bipolar pulses have been employed by mitigating an increase in tissue conductivity as would normally be observed with a comparable liquid solution. A more efficient cell permeabilisation would result in better results where electroporation is being delivered alone or as a tool to aid in the uptake of molecules into the cell.
    Type: Application
    Filed: October 18, 2023
    Publication date: March 7, 2024
    Applicant: MIRAI MEDICAL LIMITED
    Inventors: Declan SODEN, Colin FORDE, Sean KINSELLA, Tony MOORE
  • Patent number: 11912975
    Abstract: An electroporation apparatus has an electroporation probe terminals for linking with electrodes. A foam is injected at the treatment site to displace blood rather than mixing with it, increasing the contact time of a higher concentration of active agent with the tissue and thus resulting in greater efficacy. With foam solutions, a lower concentration of agent can be used to obtain the same therapeutic effect as in their liquid counterpart, reducing the prevalence of side effects associated with higher concentrations. A foam solution compared to an equivalent liquid solution enables more efficient cell electroporation particularly where bipolar pulses have been employed by mitigating an increase in tissue conductivity as would normally be observed with a comparable liquid solution. A more efficient cell permeabilization would result in better results where electroporation is being delivered alone or as a tool to aid in the uptake of molecules into the cell.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: February 27, 2024
    Assignee: MIRAI MEDICAL LIMITED
    Inventors: Declan Soden, Colin Forde, Sean Kinsella, Tony Moore
  • Publication number: 20220298464
    Abstract: An electroporation apparatus has an electroporation probe terminals for linking with electrodes. A foam is injected at the treatment site to displace blood rather than mixing with it, increasing the contact time of a higher concentration of active agent with the tissue and thus resulting in greater efficacy. With foam solutions, a lower concentration of agent can be used to obtain the same therapeutic effect as in their liquid counterpart, reducing the prevalence of side effects associated with higher concentrations. A foam solution compared to an equivalent liquid solution enables more efficient cell electroporation particularly where bipolar pulses have been employed by mitigating an increase in tissue conductivity as would normally be observed with a comparable liquid solution. A more efficient cell permeabilization would result in better results where electroporation is being delivered alone or as a tool to aid in the uptake of molecules into the cell.
    Type: Application
    Filed: September 1, 2020
    Publication date: September 22, 2022
    Applicant: MIRAI MEDICAL LIMITED
    Inventors: Declan SODEN, Colin FORDE, Sean KINSELLA, Tony MOORE
  • Patent number: 11172844
    Abstract: A monitoring method is performed by a digital processor while a subject is asleep or with little movement. The method includes receiving transducer signals for a subject and training a model for characteristics of a subject or subject group. The model is used in generating sleep data according to real-time correspondence and values of transducer signals including subject rib displacement, subject abdomen displacement, subject torso movement, and subject orientation. Combinations of the transducer inputs are used to determine features from which outputs such as an AHI score are determined. A feature matrix is normalized based on dynamically-generated positional epochs bordered by subject movements to new positions and used to provide a normalization matrix.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: November 16, 2021
    Assignee: PMD Device Solutions Limited
    Inventors: Myles Murray, Christopher Kinsella, Kevin Sweeney, Seán Kinsella
  • Publication number: 20190150787
    Abstract: A monitoring method is performed by a digital processor while a subject is asleep or with little movement. The method includes receiving transducer signals for a subject and training a model for characteristics of a subject or subject group. The model is used in generating sleep data according to real-time correspondence and values of transducer signals including subject rib displacement, subject abdomen displacement, subject torso movement, and subject orientation. Combinations of the transducer inputs are used to determine features from which outputs such as an AHI score are determined. A feature matrix is normalized based on dynamically-generated positional epochs bordered by subject movements to new positions and used to provide a normalization matrix.
    Type: Application
    Filed: May 18, 2017
    Publication date: May 23, 2019
    Applicant: PMD Device Solutions Limited
    Inventors: Myles MURRAY, Christopher KINSELLA, Kevin SWEENEY, Seán KINSELLA